Faricimab (Anti-Angiopoietin 2 & VEGF-A)
£411.00
Faricimab (Anti-Angiopoietin 2 & VEGF-A) (A4052-1mg)
Product
| Cat # A4052-1mg | Size 1mg |
Price
£411.00
|
Qty
|
Description
Faricimab is a humanized bispecific antibody that targets vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2; Ang2; ANGPT2), key regulators of vascular leakage and inflammation. It is used to treat neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema due to retinal vein occlusion, improving retinal vascular stability. M.W 146.41 kDa
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Product Size | 1mg |
| Manufacturer Cat# | A4052 |
| Target | VEGFR |